Xylocaine Injection, Solution
Product Images NDC 51662-1622

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 51662-1622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

How Supplied (51662 1622 How Supplied)

A data table listing NDC codes, strengths, and packaging details for Xylocaine (lidocaine HCl and epinephrine injection, USP) with epinephrine 1:100,000. The strength is 10 mg per mL, with packaging options including 20 mL multiple dose vials, vials in pouches, and vials in cases of 25.*

FDA Label Image

Structure (51662 1622 Structure 1)

Chemical structure of the active ingredient in XYLOCAINE injection solution, showing molecular components including a benzene ring with two methyl groups, amide linkage, and diethylamino group, along with hydrochloride (HCl).*

FDA Label Image

Structure (51662 1622 Structure 2)

Chemical structure diagram of the active ingredient in XYLOCAINE injection solution, showing a phenol ring with two hydroxyl groups and a side chain including a hydroxyl group and a methylated amine.*

FDA Label Image

Table 1 (51662 1622 Table 1)

A table listing drug classes and examples of drugs in each class. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with examples such as lidocaine and bupivacaine under Local anesthetics.*

FDA Label Image

Table 2 (51662 1622 Table 2 Part 2)

A partial data table listing dosage or procedural information for XYLOCAINE injection solution, including entries for paracervical obstetrical analgesia, sympathetic nerve blocks (cervical and lumbar), and central neural blocks (epidural, thoracic, lumbar), with numerical columns corresponding to quantities or doses, though header labels are not visible in the image.*

FDA Label Image

Table 2 (51662 1622 Table 2 Part 3)

A data table presenting dosage information for XYLOCAINE injection solution, showing doses related to caudal, obstetrical analgesia, and surgical anesthesia use. The table includes numeric values likely indicating dosage amounts or parameters across different columns.*

FDA Label Image

Table 2 (51662 1622 Table 2 Part1)

Table titled 'Recommended Dosages' for Xylocaine (lidocaine hydrochloride) injection without epinephrine. It lists various infiltration procedures like percutaneous, intravenous regional, and different peripheral nerve blocks, with corresponding concentration percentages, volume in mL, and total dose in mg for each procedure.*

FDA Label Image

Rfid Label (51662 1622 1 Rfid Label)

A close-up of a barcode label on packaging for XYLOCAINE injection, solution. The label includes a data matrix barcode, various numeric codes, and text indicating distribution by HF Acquisitions Co., LLC in Mukilteo, WA 98275. The label also notes 'SEE MANUFACTURE'S INSERT' and 'RX ONLY'.*

FDA Label Image

Vial Label (51662 1622 1 Vial)

Xylocaine 1% (lidocaine HCl and epinephrine injection, USP) solution in a 20 mL multiple dose vial. The label indicates a concentration of 200 mg per 20 mL (10 mg per mL) with epinephrine 1:100,000. It is intended for infiltration and nerve block, and specifically states it is not for caudal or epidural use. The vial has a red cap and is labeled for prescription use by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Pouch Label (51662 1622 2 Pouch)

XYLOCAINE injection, solution vial containing Lidocaine HCl 10 mg/mL with epinephrine 0.01 mg/mL (1:100,000), 20 mL vial. Label includes NDC 51662-1622-2, lot number, expiration date, and storage instructions. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA. The label specifies use for infiltration and nerve block, not for caudal or epidural use.*

FDA Label Image

Case Label (51662 1622 3 Case Label)

Label for XYLOCAINE injection, solution containing lidocaine HCl and epinephrine (EPI) at 10 mg/mL strength in a 20 mL vial. The label includes NDC 51662-1622-3, lot number, and expiration date. It indicates use for infiltration and nerve block, lists inactive ingredients, and states it is manufactured by HF Acquisition Co LLC in Mukilteo, WA. The label notes storage conditions and cautions about product appearance.*

FDA Label Image

Rfid Label (51662 1622 3 Rfid)

Partial view of a packaging label for XYLOCAINE injection, solution. The label shows a barcode, multiple numeric codes likely related to product identification and batch information, and text indicating distribution by HF Acquisitions Co., LLC, Mukilteo, WA 98275. The label advises to see the manufacturer's insert for instructions and storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.